Skye Bioscience SKYE
NASDAQ SKYE
$1.07 -0.03 (-2.29%)
At close: Nov 16, 2026 · 4:00 PM EST

Skye Bioscience (SKYE) Purchase of Investments (2025)

Updated

Analysis

Skye Bioscience (SKYE) Purchase of Investments (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Purchased (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 258.00 Mn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 919.00 Mn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 300.00 Mn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn -
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 1.00 Mn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 4.40 Bn
10 Skye Bioscience 5.38 Mn -52.34 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 2.98 Mn
Sep 30, 2025 -7.88 Mn
Jun 30, 2025 11.94 Mn
Mar 31, 2025 12.80 Mn
API Access

Skye Bioscience Purchase of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=purchase-of-investments&ticker=SKYE&period=max&api_key=YOUR_API_KEY